MDS Trial Breakthrough FDA and Bexmarilumab Next Steps

By Proactive Investors / March 13, 2026 / www.youtube.com / Article Link

Faron Pharmaceuticals is raising EUR40M to advance its immunotherapy drug bexmarilimab into a randomized Phase 2 trial for ...

Recent News

Energy outperforms gold and tech for first time in years

March 23, 2026 / www.canadianminingreport.com

Gold stocks crash along with metal price

March 23, 2026 / www.canadianminingreport.com

Mining stock ETFs slide, gold sector valuations high

March 16, 2026 / www.canadianminingreport.com

Rise in oil price a potential net gain for Canada

March 16, 2026 / www.canadianminingreport.com

Gold stocks slump partly on fears of cost increases

March 09, 2026 / www.canadianminingreport.com

See all >